complement C4B (Chido/Rodgers blood group)
| GO Term | Evidence Code | PMID |
|---|---|---|
| inflammatory response | ||
| complement activation | ||
| complement activation | ||
| complement activation, classical pathway | ||
| opsonization |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region | ||
| extracellular space | ||
| extracellular space | ||
| extracellular space | ||
| endoplasmic reticulum lumen |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| complement binding | ||
| complement component C1q complex binding |
|
|
| endopeptidase inhibitor activity | ||
| protein binding | ||
| carbohydrate binding |
| Gene Ontology |
|---|
| endopeptidase inhibitor activity |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0060298 | complement component 4b deficiency | |
| DOID:12361 | Graves' disease | |
| DOID:12849 | autistic disorder | |
| DOID:4450 | renal cell carcinoma | |
| DOID:7148 | rheumatoid arthritis | |
| DOID:9074 | systemic lupus erythematosus |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026